Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35

United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Tiago Girao

28 Oct 2026

Chief Financial Officer

Sell

6,606

$28.50

$188.27K

Jay S Stout

21 Oct 2026

Chief Technology Officer

Sell

2,595

$28.94

$75.10K

Jay S Stout

7 Oct 2026

Chief Technology Officer

Sell

1,596

$32.06

$51.17K

Jay S Stout

7 Oct 2026

Chief Technology Officer

Sell

2,213

$32.06

$70.95K

Melanie Gloria

7 Oct 2026

Chief Operating Officer

Sell

2,241

$32.06

$71.85K

Tuyl Christopher Van

7 Oct 2026

Chief Legal Officer

Sell

1,327

$32.06

$42.54K

What was left out

Form 4 filings counted 5

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 0

History held since 15 May 2019